Skip to main content

Advertisement

Table 3 Prescription drug classes, > 2.0% (%)

From: A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008–2015

MD Pediatric MD Adult
Anticonvulsants (15.0) Anticonvulsants (10.7)
Metabolic modifiers (8.0) Opioid agonists (6.2)
Proton pump inhibitors (4.0) Proton pump inhibitors (3.3)
Sympathomimetics (2.3) Thyroid hormone (2.9)
Selective serotonin reuptake inhibitors (2.0) Selective serotonin reuptake inhibitors (2.7)
Antiadrenergic antihypertensives (2.0) Metabolic modifiers (2.2)
Central muscle relaxants (2.1)